S Thoelen

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Angela Huttner, Christoph Hatz, Germie van den Dobbelsteen et al. · The Lancet Infectious Diseases · 2017 · 201 citations

Vaccination, Vaccine Safety, Urology +6

Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistence

Pierre Van Damme, S Thoelen, M. Cramm et al. · Journal of Medical Virology · 1994 · 159 citations

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

S Thoelen, Pierre Van Damme, Catharina Matheï et al. · Vaccine · 1998 · 157 citations

Vaccination, Viral Hepatitis, Novel Adjuvant System +9

Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody

Ron Dagan, Jacob Amir, Analia Mijalovsky et al. · The Pediatric Infectious Disease Journal · 2000 · 141 citations

The first combined vaccine against hepatitis A and B: an overview

S Thoelen, Pierre Van Damme, A Leentvaar-Kuypers et al. · Vaccine · 1999 · 121 citations

Vaccination, Vaccine Development, Viral Hepatitis +10